Vertex Pharmaceuticals (VRTX) Debt Ratio (2009 - 2016)

Vertex Pharmaceuticals' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.03 for Q4 2016.

• On a quarterly basis, Debt Ratio fell 71.1% year-over-year to 0.03 in Q4 2016; TTM through Dec 2016 was 0.03, a 71.1% decrease from a year earlier, with the FY2016 full-year figure at 0.03, down 71.1% from the prior year.
• Debt Ratio fell to 0.03 in Q4 2016 per VRTX's latest filing, from 0.11 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.14 in Q1 2015 and bottomed at 0.03 in Q4 2016.
• The 3-year median for Debt Ratio is 0.12 (2015), against an average of 0.11.
• Across the five-year window, Debt Ratio retreated 1.12% in 2015 and plunged 71.1% in 2016, its largest moves.
• Year by year, Debt Ratio stood at 0.13 in 2014, then declined by 29.04% to 0.09 in 2015, then plunged by 71.1% to 0.03 in 2016.
• Per Business Quant, the three latest VRTX Debt Ratio figures stand at 0.03 (Q4 2016), 0.11 (Q3 2016), and 0.12 (Q2 2016).